Breastfeeding and COVID-19 vaccination: position statement of the Italian scientific societies

Riccardo Davanzo1, Massimo Agosti2, Irene Cetin3

  • 1Institute for Maternal and Child Health - IRCCS Burlo Garofolo, Via dell'Istria 65/1, 34100, Trieste, Italy. riccardo.davanzo@gmail.com.

Insights

COVID-19 vaccination is compatible with breastfeeding. Italian scientific societies recommend vaccination for breastfeeding mothers, as the health benefits of breastfeeding outweigh potential risks to the infant.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Pediatrics

Background:

  • The introduction of COVID-19 vaccines prompted questions about their safety during breastfeeding.
  • Limited data currently exists on COVID-19 vaccine administration to breastfeeding mothers.

Discussion:

  • Major Italian scientific societies, including those for Neonatology, Pediatrics, Perinatal Medicine, Obstetrics and Gynecology, and Infectious Diseases, collaborated on a consensus statement.
  • The consensus addresses the compatibility of COVID-19 vaccination with breastfeeding.
  • The statement acknowledges the limited current knowledge but emphasizes the well-established benefits of breastfeeding.

Key Insights:

  • Biological plausibility suggests a low health risk to the breastfed infant.
  • The health benefits of breastfeeding are significant and well-documented.
  • Italian scientific societies conclude that COVID-19 vaccination does not pose a significant risk to breastfed infants.

Outlook:

  • Further research may provide more specific data on COVID-19 vaccine effects in breastfeeding dyads.
  • Continued monitoring of vaccine safety in this population is warranted.
  • The consensus supports informed decision-making for breastfeeding mothers regarding COVID-19 vaccination.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
49.2K
International Nursing Organizations I01:23

International Nursing Organizations I

International Nursing Organization (ICN) is a global union of national nurses' organizations. Individual nurses can be a part of ICN through member organizations. Each member organization strives to ensure quality nursing care, sound health policies, the advancement of nursing knowledge, respect for the profession, and a satisfied and competent nursing workforce.
ICN member organizations work to advance the field of nursing and healthcare via policies, partnerships, lobbying, professional...
2.0K
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
3.7K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
619
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
578
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.7K